ArticleAIDS and behavior2026
HIV and Syphilis Seroprevalence and Correlates of HIV-Syphilis Co-infection Among Black and Latina Women of Transgender Experience and Transfeminine People in Los Angeles County, 2023-2024.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Women of transgender experience and transfeminine people (WTE/TFP) are disproportionately impacted by HIV, yet local data on syphilis seroprevalence and HIV-syphilis co-infection among Black and Latina WTE/TFP in Los Angeles County (LAC) remain limited. This study examined HIV and treponemal syphilis seroprevalence and identified correlates of HIV-syphilis co-infection among Black and Latina WTE/TFP in LAC. From August 2023 through June 2024, the National HIV Behavioral Surveillance (NHBS) in LAC recruited WTE/TFP using respondent-driven sampling. Among 352 non-Hispanic Black (n = 99) and Latina (n = 253) participants with valid HIV and treponemal syphilis test results, HIV seroprevalence was 42%, treponemal syphilis seroprevalence was 56%, and HIV-syphilis co-infection was 33%, indicating substantial overlap of the two epidemics. Structural vulnerability was widespread, including food insecurity (70%), incarceration history (46%), homelessness (39%), and unemployment (39%). Co-infection was unevenly distributed. In adjusted analysis, Black participants had a 70% higher prevalence of co-infection than Latina participants (aPR = 1.70, 95% CI 1.14-2.52), and methamphetamine use was associated with nearly twice the prevalence of co-infection (aPR = 1.89, 95% CI 1.22-2.94). Continued efforts to expand routine syphilis screening, timely staging and treatment, doxycycline post-exposure prophylaxis education and counseling, and integrated harm reduction services are vital to addressing this overlapping epidemic. These findings also support sustained investment in Black-centered, peer-led trans community organizations and trans-competent clinical care to better address the co-occurring HIV and syphilis burden among Black and Latina WTE/TFP in LAC.
Indexed as
Identifiers
42435279What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.